Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Pediatr Crit Care Med ; 18(2): e86-e91, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-28157809

RESUMEN

OBJECTIVES: Withdrawal syndrome is an adverse reaction of analgesic and sedative therapy, with a reported occurrence rate between 17% and 57% in critically ill children. Although some factors related to the development of withdrawal syndrome have been identified, there is weak evidence for the effectiveness of preventive and therapeutic strategies. The main aim of this study was to evaluate the frequency of withdrawal syndrome in Italian PICUs, using a validated instrument. We also analyzed differences in patient characteristics, analgesic and sedative treatment, and patients' outcome between patients with and without withdrawal syndrome. DESIGN: Observational multicenter prospective study. SETTING: Eight Italian PICUs belonging to the national PICU network Italian PICU network. PATIENTS: One hundred thirteen patients, less than 18 years old, mechanically ventilated and treated with analgesic and sedative therapy for five or more days. They were admitted in PICU from November 2012 to May 2014. INTERVENTIONS: Symptoms of withdrawal syndrome were monitored with Withdrawal Assessment Tool-1 scale. MEASUREMENTS AND MAIN RESULTS: The occurrence rate of withdrawal syndrome was 64.6%. The following variables were significantly different between the patients who developed withdrawal syndrome and those who did not: type, duration, and cumulative dose of analgesic therapy; duration and cumulative dose of sedative therapy; clinical team judgment about analgesia and sedation's difficulty; and duration of analgesic weaning, mechanical ventilation, and PICU stay. Multivariate logistic regression analysis revealed that patients receiving morphine as their primary analgesic were 83% less likely to develop withdrawal syndrome than those receiving fentanyl or remifentanil. CONCLUSIONS: Withdrawal syndrome was frequent in PICU patients, and patients with withdrawal syndrome had prolonged hospital treatment. We suggest adopting the lowest effective dose of analgesic and sedative drugs and frequent reevaluation of the need for continued use. Further studies are necessary to define common preventive and therapeutic strategies.


Asunto(s)
Analgésicos/efectos adversos , Cuidados Críticos/métodos , Hipnóticos y Sedantes/efectos adversos , Unidades de Cuidado Intensivo Pediátrico , Síndrome de Abstinencia a Sustancias/diagnóstico , Síndrome de Abstinencia a Sustancias/epidemiología , Adolescente , Analgésicos/administración & dosificación , Niño , Preescolar , Femenino , Humanos , Hipnóticos y Sedantes/administración & dosificación , Enfermedad Iatrogénica/epidemiología , Lactante , Recién Nacido , Italia/epidemiología , Modelos Logísticos , Masculino , Estudios Prospectivos , Respiración Artificial , Síndrome de Abstinencia a Sustancias/etiología
3.
Acta Biomed ; 83 Suppl 1: 27-32, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23029874

RESUMEN

Exogenous surfactant is a therapeutic option for newborns, children and adults with acute respiratory distress disorders. Although tracheal instillation is still reputed as the classical method of surfactant delivery, alternative techniques have been investigated. Surfactant administration by using thin intra-tracheal catheters, bronchoscopy, laryngeal mask airway, or nebulisation, although variably effective, appear to be less invasive when compared to tracheal intubation. However, further research is still needed to better clarify this matter. (www.actabiomedica.it).


Asunto(s)
Lesión Pulmonar Aguda/tratamiento farmacológico , Sistemas de Liberación de Medicamentos/instrumentación , Sistemas de Liberación de Medicamentos/métodos , Surfactantes Pulmonares/administración & dosificación , Síndrome de Dificultad Respiratoria del Recién Nacido/tratamiento farmacológico , Adulto , Niño , Humanos , Recién Nacido , Intubación Intratraqueal , Máscaras Laríngeas , Nebulizadores y Vaporizadores
4.
Am J Med Genet A ; 146A(7): 861-72, 2008 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-18203198

RESUMEN

Twenty-five medical centers and the Prader-Willi Syndrome (PWS) Association collaborated on a study which attempted to identify all people with genetically confirmed diagnosis of PWS living in Italy. Investigators of the participating centers contacted PWS subjects and/or their family, filled in a specially developed form with the required data and forwarded this information by email. The study identified 425 subjects (209 males and 216 females, between the ages of 0.4-46.7). Two hundred thirty-eight patients had del15, 104 had UPD15, 4 demonstrated a translocation affecting chromosome 15 and 79 showed a positive methylation test. There were fewer subjects found over the age of 35, probably due to the low rate of identification of older PWS patients as well as the high mortality rate. There were a greater number of male children and adolescents with PWS whilst, amongst adults, there were more females. As expected, the majority of subjects with PWS were obese, especially in adult life. Nevertheless, it is noteworthy that 26% of patients aged between 6 and 17 were normal weight. A total of 212 subjects had received GH treatment, of which 141 were still receiving therapy, while the remaining 71 had stopped. In children and adolescents (233 cases), 89 subjects had never undergone GH therapy. Eighteen PWS patients had died in the past 20 years. Obesity-related cardiovascular and respiratory diseases were the cause of death, both during childhood and after 18 years of age. Three children died suddenly whilst undergoing GH therapy. Respiratory infection and cardiac illness were the causes of death in two cases. There was no definitive cause of death found in the third case. Overall, there was no increase in number of deaths during GH treatment, suggesting that GH administration in patients with PWS, as a group, does not increase the risk of death.


Asunto(s)
Síndrome de Prader-Willi/epidemiología , Adolescente , Adulto , Índice de Masa Corporal , Niño , Preescolar , Cromosomas Humanos Par 15 , Femenino , Hormona del Crecimiento/uso terapéutico , Humanos , Hibridación Fluorescente in Situ , Lactante , Italia/epidemiología , Masculino , Persona de Mediana Edad , Obesidad/complicaciones , Síndrome de Prader-Willi/complicaciones , Síndrome de Prader-Willi/tratamiento farmacológico , Síndrome de Prader-Willi/fisiopatología
5.
Pediatr Pulmonol ; 38(3): 269-71, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15274110

RESUMEN

Phrenic nerve paralysis is a condition typically occurring after invasive procedures in the chest and neck. Here we describe a case of transient unilateral diaphragmatic paralysis in a child with status asthmaticus complicated by complete right lung atelectasis. Common causes of this disorder and possible implications for our case are discussed.


Asunto(s)
Paresia/etiología , Nervio Frénico , Estado Asmático/complicaciones , Broncoscopía , Niño , Humanos , Masculino , Paresia/diagnóstico , Factores de Tiempo
6.
Pediatr Rep ; 4(1): e13, 2012 Jan 02.
Artículo en Inglés | MEDLINE | ID: mdl-22690305

RESUMEN

Septic shock remains a major cause of morbidity and mortality among children, mainly due to acute hemodynamic compromise and multiple organ failures. In the last decade, international guidelines for the management of septic shock, as well as clinical practice parameters for hemodynamic support of pediatric patients, have been published. Early recognition and aggressive therapy of septic shock, by means of abundant fluid resuscitation, use of catecholamines and other adjuvant drugs, are widely considered of pivotal importance to improve the short and long-term outcome of these patients. The aim of this paper is to summarize the modern approach to septic shock in children, particularly in its very initial phase, when pediatric healthcare providers may be required to intervene in the pre-intensive care unit setting or just on admission in the pediatric intensive care unit.

7.
World J Pediatr Congenit Heart Surg ; 2(3): 505-8, 2011 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-23804006

RESUMEN

Double-outlet left ventricle is an exceedingly rare congenital heart defect. Its prenatal detection and precise anatomical definition are challenging for a variety of reasons and have never been previously reported. Here described are 2 cases of prenatally diagnosed double-outlet left ventricle. The technical limitations of prenatal diagnosis and its implications for the surgical management of patients affected by such a rare condition are discussed.

8.
Clin Biochem ; 41(14-15): 1150-5, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18606160

RESUMEN

OBJECTIVES: To compare the accuracy of procalcitonin (PCT) in early-onset neonatal sepsis (EOS) using standard cut-off values and a multilevel probabilistic approach. DESIGN AND METHODS: A retrospective study of PCT was performed in 149 newborns at risk of EOS, including preterm or prolonged rupture of membranes, chorioamnionitis or maternal infection, GBS colonization and signs of fetal distress. PCT values were analysed according to time of assay, i.e. at birth and at 24 and 48 h. We estimated sensitivity, specificity, positive (LR+) and negative likelihood ratio (LR-), diagnostic odds ratio (DOR) and number needed to diagnose (NND) using traditional and optimal (derived from ROC analysis) PCT cut-off values. RESULTS: Using optimal cut-off, the LR+, DOR and NND at birth were 10, 18.9 and 2.2, at 24 h they were 5.3, 11.2 and 2.1, and at 48 h they were 5.6, 18.1 and 1.7, respectively. The multilevel analysis generated three post-test probabilities for each time of assay. At 24 h post-test probabilities of EOS were 78% for PCT >90, 11% for PCT 10.1-90 and 3% for PCT <10.1 mg/L, respectively. Similar results were found in the other time points, with a wide range of intermediate PCT concentrations that did not change the post-test probability. CONCLUSIONS: The multilevel probabilistic approach was more effective in assessing the diagnostic power of PCT in EOS, showing that a wide range of intermediate PCT values was not able to discriminate between presence and absence of infection.


Asunto(s)
Calcitonina/sangre , Enfermedades del Recién Nacido/diagnóstico , Enfermedades del Recién Nacido/epidemiología , Modelos Estadísticos , Precursores de Proteínas/sangre , Sepsis/diagnóstico , Sepsis/epidemiología , Edad de Inicio , Bioensayo , Péptido Relacionado con Gen de Calcitonina , Humanos , Recién Nacido , Enfermedades del Recién Nacido/sangre , Italia/epidemiología , Funciones de Verosimilitud , Curva ROC , Factores de Riesgo , Sepsis/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA